Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2Gastrointestinal 2Breast 1

Conditions

Prostatic Neoplasms 2Fasting 1

Interventions

Docetaxel 205Prednisone 151enzalutamide 128Gemcitabine 123Radiotherapy 117Sunitinib 112Cisplatin 103Leuprolide 98pembrolizumab 96Abiraterone Acetate 94bicalutamide 87Nivolumab 85Goserelin 83Sorafenib 80Paclitaxel 79Carboplatin 77Everolimus 72Bevacizumab 71Magnetic Resonance Spectroscopy 66acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 61pazopanib 56radium Ra 223 dichloride 50Ipilimumab 49Zoledronic Acid 47Cyclophosphamide 44Radiosurgery 43Filgrastim 42abiraterone 41gallium 68 PSMA-11 40Surveys and Questionnaires 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Angptl4 protein, mouse × Genitourinary × Clear all
NCT05764330 2025-08-06

Weight Loss Interventions to Reduce Cancer Progression in Prostate Cancer Patients Under Active Surveillance

Roswell Park Cancer Institute

Phase NA Completed
20 enrolled
Genitourinary

Prostatic Neoplasms

NCT02710721 2022-12-13

Fasting and Nutritional Therapy in Patients With Advanced Metastatic Prostate Cancer

Charite University, Berlin, Germany

Phase NA Completed
49 enrolled
Genitourinary

Fasting, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡